AR016128A1 - A PHARMACEUTICAL COMPOSITION THAT INCLUDES A SEROTONINE RECOVERY INHIBITOR AND A BETA-BLOCKING AND THE SAME USE OF THE SAME FOR THE PRODUCTION OF A MEDICINAL PRODUCT. - Google Patents
A PHARMACEUTICAL COMPOSITION THAT INCLUDES A SEROTONINE RECOVERY INHIBITOR AND A BETA-BLOCKING AND THE SAME USE OF THE SAME FOR THE PRODUCTION OF A MEDICINAL PRODUCT.Info
- Publication number
- AR016128A1 AR016128A1 ARP980103371A ARP980103371A AR016128A1 AR 016128 A1 AR016128 A1 AR 016128A1 AR P980103371 A ARP980103371 A AR P980103371A AR P980103371 A ARP980103371 A AR P980103371A AR 016128 A1 AR016128 A1 AR 016128A1
- Authority
- AR
- Argentina
- Prior art keywords
- same
- beta
- pharmaceutical composition
- production
- acronym
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se refiere a una composicion farmacéutica que comprende un SSRI (siglas por las que representa a los inhibidores selectivos de la captacion de serotonina)en forma de liberacion rápida y un beta-bloqueante en forma de liberacion sostenida y al empleode la misma para la produccion de un medicamento para eltratamiento o la prevencion de alcoholismo, ansiedad, depresion, trastorno obsesivo compulsivo (designado por las siglas OCD), trastorno de pánico, dolorcronico, obesidad, demencia senil, migrana, bulimia, anorexia, fobia social, síndrome premenstrual(designado por las siglas PMS), depresion de la adolescencia,tricotilomanía, distimia y abuso de sustancias.It refers to a pharmaceutical composition comprising an SSRI (acronym for which it represents the selective serotonin uptake inhibitors) in the form of rapid release and a beta-blocker in the form of sustained release and the use thereof for the production of a drug for the treatment or prevention of alcoholism, anxiety, depression, obsessive compulsive disorder (designated by the acronym OCD), panic disorder, synchronic pain, obesity, senile dementia, migraine, bulimia, anorexia, social phobia, premenstrual syndrome (designated by the acronym PMS), depression of adolescence, trichotillomania, dysthymia and substance abuse.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016128A1 true AR016128A1 (en) | 2001-06-20 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103371A AR016128A1 (en) | 1997-07-11 | 1998-07-10 | A PHARMACEUTICAL COMPOSITION THAT INCLUDES A SEROTONINE RECOVERY INHIBITOR AND A BETA-BLOCKING AND THE SAME USE OF THE SAME FOR THE PRODUCTION OF A MEDICINAL PRODUCT. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (en) |
| JP (1) | JP2002508003A (en) |
| KR (1) | KR20010021644A (en) |
| CN (1) | CN1262627A (en) |
| AP (1) | AP2000001728A0 (en) |
| AR (1) | AR016128A1 (en) |
| AU (1) | AU9340198A (en) |
| BG (1) | BG104119A (en) |
| BR (1) | BR9810996A (en) |
| CA (1) | CA2295822A1 (en) |
| CO (1) | CO4950552A1 (en) |
| DZ (1) | DZ2556A1 (en) |
| EA (1) | EA200000112A1 (en) |
| GB (1) | GB9714675D0 (en) |
| HU (1) | HUP0003074A3 (en) |
| ID (1) | ID24191A (en) |
| IL (1) | IL133869A0 (en) |
| MA (1) | MA24604A1 (en) |
| NO (1) | NO20000107D0 (en) |
| OA (1) | OA11276A (en) |
| PE (1) | PE99699A1 (en) |
| PL (1) | PL338017A1 (en) |
| SK (1) | SK72000A3 (en) |
| TR (1) | TR200000074T2 (en) |
| WO (1) | WO1999002142A2 (en) |
| ZA (1) | ZA986138B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE457169T1 (en) | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | COMPOUNDS FOR THE TREATMENT OF WEIGHT LOSS |
| PT1126826E (en) | 1998-11-02 | 2008-11-25 | Elan Pharma Int Ltd | Multiparticulate modified release composition of methylphenidate |
| KR101476574B1 (en) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | Controlled release hydrocodone formulations |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| MXPA03003895A (en) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Controlled release hydrocodone formulations. |
| WO2006030306A2 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (en) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | Slowly released tablet of compound atenolol, and preparation method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (en) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablet for the enteral administration of indolyloxyalkanolamine derivatives |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug response by a serotonin 1A receptor antagonist |
| DE69607904T2 (en) * | 1995-08-16 | 2000-10-05 | Lilly Co Eli | Potentiation of serotonin drug response |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 SK SK7-2000A patent/SK72000A3/en unknown
- 1998-07-07 CN CN98806975A patent/CN1262627A/en active Pending
- 1998-07-07 PL PL98338017A patent/PL338017A1/en unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/en unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 IL IL13386998A patent/IL133869A0/en unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/en unknown
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/en not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 EA EA200000112A patent/EA200000112A1/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/en unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/en active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/en not_active Application Discontinuation
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/en active
- 1998-07-10 AR ARP980103371A patent/AR016128A1/en unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/en unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/en unknown
- 1998-07-10 MA MA25165A patent/MA24604A1/en unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/en not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107D0/en not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810996A (en) | 2000-08-08 |
| PL338017A1 (en) | 2000-09-25 |
| IL133869A0 (en) | 2001-04-30 |
| CA2295822A1 (en) | 1999-01-21 |
| SK72000A3 (en) | 2000-12-11 |
| OA11276A (en) | 2003-07-31 |
| CO4950552A1 (en) | 2000-09-01 |
| HUP0003074A2 (en) | 2001-01-29 |
| HUP0003074A3 (en) | 2001-12-28 |
| PE99699A1 (en) | 1999-12-21 |
| AU9340198A (en) | 1999-02-08 |
| ID24191A (en) | 2000-07-13 |
| ZA986138B (en) | 2000-01-10 |
| JP2002508003A (en) | 2002-03-12 |
| DZ2556A1 (en) | 2003-02-15 |
| WO1999002142A2 (en) | 1999-01-21 |
| MA24604A1 (en) | 1999-04-01 |
| CN1262627A (en) | 2000-08-09 |
| GB9714675D0 (en) | 1997-09-17 |
| NO20000107L (en) | 2000-01-10 |
| NO20000107D0 (en) | 2000-01-10 |
| KR20010021644A (en) | 2001-03-15 |
| AP2000001728A0 (en) | 2000-03-31 |
| EP0996466A2 (en) | 2000-05-03 |
| TR200000074T2 (en) | 2000-05-22 |
| WO1999002142A3 (en) | 1999-04-15 |
| EA200000112A1 (en) | 2000-10-30 |
| BG104119A (en) | 2000-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016128A1 (en) | A PHARMACEUTICAL COMPOSITION THAT INCLUDES A SEROTONINE RECOVERY INHIBITOR AND A BETA-BLOCKING AND THE SAME USE OF THE SAME FOR THE PRODUCTION OF A MEDICINAL PRODUCT. | |
| BR122012023120B8 (en) | Serotonin reuptake inhibitor compound | |
| HRP20080478T3 (en) | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors | |
| Koufaki et al. | Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage | |
| NO20060402L (en) | 3-amino choman and 2-aminotetraline derivatives | |
| WO2007050783A3 (en) | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension | |
| BRPI0407993A (en) | p38 inhibitors and methods for using them | |
| HRP20080262T3 (en) | 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
| AR035782A1 (en) | SUBSTITUTED AMIDAS OF BENZOFURAN-2-CARBOXILIC ACID, A PROCEDURE FOR THEIR PREPARATION, THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT | |
| NO20070914L (en) | Methods for treating nervous system disorders and conditions | |
| MY136262A (en) | Phenyl heterocyclyl ethers | |
| DK1545552T3 (en) | Combination therapy using a serotin reuptake inhibitor | |
| IS2425B (en) | New heteroaryl derivatives, their production and use | |
| ATE334989T1 (en) | ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-FÖCHINOXALINE | |
| ATE304016T1 (en) | ANTIDEPRESSANT (SSSRI) AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZACYCLOPENTA (A) NAPHTHALINE | |
| BR0115276A (en) | Pharmaceutical compositions, use of at least one of the compounds, compounds, and process for preparing a pharmaceutical composition | |
| AR042379A1 (en) | NEW CYCLLOBUTAINDOL CARBOXAMIDE COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| UA81469C2 (en) | 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
| BRPI0412268A (en) | compounds containing a selective serotonin reuptake inhibitor and 5-ht2a receptor antagonist | |
| NO20000199L (en) | Medications containing polyhydroxybutylpyrazines, new polyhydroxybutylpyrazines and their preparation | |
| DE602004019698D1 (en) | MORPHOLINE DERIVATIVES AS INHIBITORS OF THE RECOVERY OF NOREPINEPHRIN | |
| AR039723A1 (en) | COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED | |
| ATE522206T1 (en) | DEVICE AND PATCH FOR THE CONTROLLED RELEASE OF VANILLIN | |
| MXPA03011766A (en) | Novel indole derivatives. | |
| EA200601158A1 (en) | COMBINATION OF SEROTONIN RETURN CAPTURE INHIBITOR AND ANTAGONIST, REVERSE AGONIST OR PARTIAL AGONIST OF HISTAMINE 3 RECEPTOR |